Gennova Biopharmaceuticals Ltd

India could step up to the plate with a vaccine to prevent mpox, classified as a public health emergency of international concern (PHEIC) once again post 2022 by the World Health Organization (WHO) af

India is gradually building an innovation ecosystem with an eye on self-reliance. AI-led initiatives, startup support, a crunch in timelines for regulatory approvals of innovative products by at least

{C#3380:Zydus Lifesciences Limited], India’s only company to have gained an approval for a biosimilar antibody-drug conjugate (ADC), is now working on its own novel oncology ADC. “We are developing a

Top executives of Merck Life Science, Merck KGaA ’s arm offering research and manufacturing products and solutions for chemical and biological drugs, in India say “almost everyone” in the biologics s